These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 8312222)
1. Structure of the VH and VL segments of polyreactive and monoreactive human natural antibodies to HIV-1 and Escherichia coli beta-galactosidase. Harindranath N; Ikematsu H; Notkins AL; Casali P Int Immunol; 1993 Dec; 5(12):1523-33. PubMed ID: 8312222 [TBL] [Abstract][Full Text] [Related]
2. Structure of the VH and VL segments of monoreactive and polyreactive IgA autoantibodies to DNA in patients with systemic lupus erythematosus. Kasaian MT; Ikematsu H; Balow JE; Casali P J Immunol; 1994 Mar; 152(6):3137-51. PubMed ID: 8144908 [TBL] [Abstract][Full Text] [Related]
3. Complete sequence of the genes encoding the VH and VL regions of low- and high-affinity monoclonal IgM and IgA1 rheumatoid factors produced by CD5+ B cells from a rheumatoid arthritis patient. Harindranath N; Goldfarb IS; Ikematsu H; Burastero SE; Wilder RL; Notkins AL; Casali P Int Immunol; 1991 Sep; 3(9):865-75. PubMed ID: 1718404 [TBL] [Abstract][Full Text] [Related]
4. Structural analysis of the VH-D-JH segments of human polyreactive IgG mAb. Evidence for somatic selection. Ikematsu H; Kasaian MT; Schettino EW; Casali P J Immunol; 1993 Oct; 151(7):3604-16. PubMed ID: 8376796 [TBL] [Abstract][Full Text] [Related]
5. Human rheumatoid B-1a (CD5+ B) cells make somatically hypermutated high affinity IgM rheumatoid factors. Mantovani L; Wilder RL; Casali P J Immunol; 1993 Jul; 151(1):473-88. PubMed ID: 7686945 [TBL] [Abstract][Full Text] [Related]
6. Nucleotide sequence analysis of the VL and VH domains of five human IgM directed to lamin B. Evidence for an antigen-driven process in the generation of human autoantibodies to lamin B. Mariette X; Brouet JC; Danon F; Tsapis A; Lassoued K Arthritis Rheum; 1993 Sep; 36(9):1315-24. PubMed ID: 8216425 [TBL] [Abstract][Full Text] [Related]
7. Variable region genes of anti-HIV human monoclonal antibodies: non-restricted use of the V gene repertoire and extensive somatic mutation. Moran MJ; Andris JS; Matsumato Y; Capra JD; Hersh EM Mol Immunol; 1993 Nov; 30(16):1543-51. PubMed ID: 8232339 [TBL] [Abstract][Full Text] [Related]
8. Variable region gene utilization and mutation in a group of neutralizing murine anti-human immunodeficiency virus type 1 principal neutralizing determinant antibodies. Pirofski LA; Thomas EK; Scharff MD AIDS Res Hum Retroviruses; 1993 Jan; 9(1):41-9. PubMed ID: 7678971 [TBL] [Abstract][Full Text] [Related]
9. Clonal analysis of a human antibody response. II. Sequences of the VH genes of human IgM, IgG, and IgA to rabies virus reveal preferential utilization of VHIII segments and somatic hypermutation. Ikematsu H; Harindranath N; Ueki Y; Notkins AL; Casali P J Immunol; 1993 Feb; 150(4):1325-37. PubMed ID: 8432980 [TBL] [Abstract][Full Text] [Related]
10. Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments. Ichiyoshi Y; Casali P J Exp Med; 1994 Sep; 180(3):885-95. PubMed ID: 8064239 [TBL] [Abstract][Full Text] [Related]
11. Analysis of VH and VL genes of a monospecific human anti-myosin antibody produced by a B cell from the primary repertoire. Laroche-Traineau J; Biard-Piechaczyk M; Jacobin MJ; Chagnaud JL; Pau B; Nurden A; Clofent-Sanchez G Hum Antibodies; 1999; 9(3):177-88. PubMed ID: 10690632 [TBL] [Abstract][Full Text] [Related]
12. Structural aspects of human IgM antibodies expressed in chronic B lymphocytic leukemia. Ramsland PA; Brock CR; Moses J; Robinson BG; Edmundson AB; Raison RL Immunotechnology; 1999 Mar; 4(3-4):217-29. PubMed ID: 10231091 [TBL] [Abstract][Full Text] [Related]
13. VH and VL gene usage by anti-beta-amyloid autoantibodies in Alzheimer's disease: detection of highly mutated V regions in both heavy and light chains. Fang Q; Kannapell CC; Fu SM; Xu S; Gaskin F Clin Immunol Immunopathol; 1995 May; 75(2):159-67. PubMed ID: 7704974 [TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of variable heavy and light chain regions of five HIV type 1-specific human monoclonal antibodies. van der Donk EM; Schutten M; Osterhaus AD; van der Heijden RW AIDS Res Hum Retroviruses; 1994 Dec; 10(12):1639-49. PubMed ID: 7888223 [TBL] [Abstract][Full Text] [Related]
15. Variable region sequences and idiotypic expression of a protective human immunoglobulin M antibody to capsular polysaccharides of Neisseria meningitidis group B and Escherichia coli K1. Azmi FH; Lucas AH; Raff HV; Granoff DM Infect Immun; 1994 May; 62(5):1776-86. PubMed ID: 8168940 [TBL] [Abstract][Full Text] [Related]
16. Restricted CDR3 length of the heavy chain is characteristic of six randomly isolated disease-associated VH J558+ IgM autoantibodies in lupus prone motheaten mice. Lipsanen V; Walter B; Emara M; Siminovitch K; Lam J; Kaushik A Int Immunol; 1997 May; 9(5):655-64. PubMed ID: 9184911 [TBL] [Abstract][Full Text] [Related]
17. Cellular origin, antigen reactivity, and VH segment structure of IgM mAbs from AIDS lymphomas. Riboldi P; Gaidano G; Schettino EW; Knowles DM; Dalla-Favera R; Casali P Ann N Y Acad Sci; 1995 Sep; 764():509-18. PubMed ID: 7486578 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the variable regions of a chimpanzee monoclonal antibody with potent neutralizing activity against HIV-1. Vijh-Warrier S; Murphy E; Yokoyama I; Tilley SA Mol Immunol; 1995 Oct; 32(14-15):1081-92. PubMed ID: 8544858 [TBL] [Abstract][Full Text] [Related]
19. Nucleotide sequences of eight human natural autoantibody VH regions reveals apparent restricted use of VH families. Sanz I; Casali P; Thomas JW; Notkins AL; Capra JD J Immunol; 1989 Jun; 142(11):4054-61. PubMed ID: 2497188 [TBL] [Abstract][Full Text] [Related]
20. Nucleotide sequence analysis of rheumatoid factors and polyreactive antibodies derived from patients with rheumatoid arthritis reveals diverse use of VH and VL gene segments and extensive variability in CDR-3. Pascual V; Victor K; Randen I; Thompson K; Steinitz M; Førre O; Fu SM; Natvig JB; Capra JD Scand J Immunol; 1992 Aug; 36(2):349-62. PubMed ID: 1502502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]